Recent Advances in Clinical Trial Design and Analysis: Cancer Treatment and Research, cartea 75
Editat de Peter F. Thallen Limba Engleză Hardback – 30 iun 1995
Recent advances in statistical computing have enabled statisticians to implement very rapidly a broad array of methods which previously were either impractical or impossible. Biostatisticians are now able to provide much greater support to medical researchers working in both clinical and laboratory settings. As our collective toolkit of techniques for analyzing data has grown, it has become increasingly difficult for biostatisticians to keep up with all the developments in our own field. Recent Advances in Clinical Trial Design and Analysis brings together biostatisticians doing cutting-edge research and explains some of the more recent developments in biostatistics to clinicians and scientists who work in clinical trials.
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1379.86 lei 6-8 săpt. | |
Springer Us – 5 oct 2012 | 1379.86 lei 6-8 săpt. | |
Hardback (1) | 1387.72 lei 6-8 săpt. | |
Springer Us – 30 iun 1995 | 1387.72 lei 6-8 săpt. |
Din seria Cancer Treatment and Research
- 5% Preț: 1080.67 lei
- 5% Preț: 711.64 lei
- 5% Preț: 771.65 lei
- 5% Preț: 1016.90 lei
- 5% Preț: 1011.74 lei
- 5% Preț: 1020.65 lei
- 5% Preț: 898.85 lei
- 5% Preț: 704.49 lei
- 5% Preț: 901.54 lei
- 5% Preț: 472.91 lei
- 5% Preț: 651.84 lei
- 5% Preț: 491.35 lei
- 5% Preț: 706.62 lei
- 5% Preț: 362.94 lei
- 15% Preț: 685.93 lei
- 5% Preț: 2073.87 lei
- 5% Preț: 1385.39 lei
- 5% Preț: 1395.26 lei
- 5% Preț: 1084.27 lei
- 5% Preț: 1271.32 lei
- 5% Preț: 1080.88 lei
- 5% Preț: 1072.26 lei
- 5% Preț: 1074.24 lei
- 5% Preț: 1384.89 lei
- 5% Preț: 705.54 lei
- 5% Preț: 692.48 lei
- 5% Preț: 716.29 lei
- 5% Preț: 1386.09 lei
- 5% Preț: 1086.24 lei
- 5% Preț: 1075.86 lei
- 5% Preț: 1070.10 lei
- 5% Preț: 1077.27 lei
- 5% Preț: 1083.90 lei
Preț: 1387.72 lei
Preț vechi: 1460.76 lei
-5% Nou
Puncte Express: 2082
Preț estimativ în valută:
265.58€ • 275.87$ • 220.60£
265.58€ • 275.87$ • 220.60£
Carte tipărită la comandă
Livrare economică 01-15 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780792332350
ISBN-10: 0792332350
Pagini: 258
Ilustrații: X, 258 p.
Dimensiuni: 170 x 244 x 21 mm
Greutate: 0.59 kg
Ediția:1995
Editura: Springer Us
Colecția Springer
Seria Cancer Treatment and Research
Locul publicării:New York, NY, United States
ISBN-10: 0792332350
Pagini: 258
Ilustrații: X, 258 p.
Dimensiuni: 170 x 244 x 21 mm
Greutate: 0.59 kg
Ediția:1995
Editura: Springer Us
Colecția Springer
Seria Cancer Treatment and Research
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
1. The alpha spending function approach to interim data analyses.- 2. Issues in the design and analysis of AIDS clinical trials.- 3. Recent developments in the design of phase II clinical trials.- 4. Multivariate failure time data.- 5. Goodness-of-fit and diagnostics for proportional hazards regression models.- 6. A review of tree-based prognostic models.- 7. Decision analysis and Bayesian methods in clinical trials.- 8. A Bayesian model for evaluating specificity of treatment effects in clinical trials.- 9. The exact analysis of contingency tables in medical research.- 10. Stratified-adjusted versus unstratified assessment of sample size and power for analyses of proportions.- 11. Quality-of-life assessment in clinical trials.
Recenzii
` ... I would recommend the book to biostatisticians who want to stay up-to-date on recent developments in the design and analysis of clinical trials.'
Annals of Oncology, 7 (1996)
` ... I can certainly recommend it as a very useful addition to a multidisciplinary library. Many of the topics coverd are yet to reach standard textbooks; their accumulation under one title is a valuable contributions.'
Clinical Oncology, 9:4 (1997)
Annals of Oncology, 7 (1996)
` ... I can certainly recommend it as a very useful addition to a multidisciplinary library. Many of the topics coverd are yet to reach standard textbooks; their accumulation under one title is a valuable contributions.'
Clinical Oncology, 9:4 (1997)